Actualités de Zug, SWITZERLAND

Medison Pharma; Alnylam Pharmaceuticals

Medison Pharma and Alnylam Pharmaceuticals Announce Expansion of their Multi-Regional Partnership in Europe and Israel to Commercialize RNAi Therapeutics in additional LATAM and APAC markets including Australia

Zug, Switzerland (ots/PRNewswire) - - The expanded partnership will allow Alnylam and Medison to help accelerate access for patients in multiple regions under one global alliance - Medison, the creator and leader of the multi-regional partnership category, will utilize its unique, unified platform for efficient ...

SHL Medical

SHL Medical partners with SteriPack Group to set up final assembly service

Zug, Switzerland (ots) - SHL Medical, a world-leading solutions provider of advanced drug delivery systems and SteriPack Group, renowned global supplier of secondary packing and final assembly services to the pharmaceutical industry, enter a non-exclusive strategic partnership. Together, they aim to establish a pre-validated final assembly service at the SteriPack ...

Medison Pharma

Medison Pharma Announces Agreement with Regeneron Pharmaceuticals to Commercialize Libtayo® (cemiplimab) in Multiple Countries

Zug, Switzerland (ots/PRNewswire) - - Libtayo (cemiplimab) is a leading PD-1 inhibitor that has shown efficacy in the treatment of certain patients with cutaneous squamous cell carcinoma, advanced basal cell carcinoma, advanced non-small cell lung cancer and advanced cervical cancer, and is approved by regulatory ...

Medison Pharma; Ipsen

Ipsen and Medison Pharma Announce Health Canada Approval of Bylvay™ (odevixibat) for the treatment of pruritus due to Progressive Familial Intrahepatic Cholestasis (PFIC)

Zug, Switzerland and Paris (ots/PRNewswire) - Bylvay (odevixibat) is the first and only oral treatment available in Canada for the treatment of pruritus due to this rare genetic condition Today, Ipsen (Euronext: IPN) (ADR: IPSEY), a global biopharmaceutical company focused on transformative medicines in oncology, ...

Capri Sun

Capri Sun to take over sales and distribution from Coca-Cola Europacific Partners in Western Europe in 2024

Zug, Switzerland (ots/PRNewswire) - Capri Sun Group Holding AG, the no. 1 kids drink brand in the world, has announced today that it will take back the sales and distribution of its iconic pouch drinks in France, Monaco, Great Britain, Netherlands, Belgium, Luxemburg, Sweden, Spain, and Portugal in 2024, bringing to ...

Klarpay AG

Klarpay AG Supports Young Athletes in Swiss Youth Olympic Sailing

Zug, Switzerland (ots/PRNewswire) - Klarpay AG, a leading global payments solution provider, is delighted to announce its partnership with Janut Angehrn and Julie Herzig, part of the Swiss Youth Olympic Sailing talent pool, as their official sponsor. This sponsorship is a testament to Klarpay's commitment to corporate social responsibility. As a proud Swiss company, Klarpay AG recognises the potential and dedication ...

Medison Pharma; Alnylam Pharmaceuticals

Alnylam Pharmaceuticals and Medison Pharma Announce the Expansion of Their Collaboration to a Multi-Regional Partnership to Commercialize RNAi Therapeutics

Zug, Switzerland (ots/PRNewswire) - Alnylam Pharmaceuticals, Inc. (Nasdaq: ALNY), the leading RNAi therapeutics company, and Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies for patients in international markets, have announced an expansion of their ...

Medison Pharma

Sarah Otten Joins Medison Pharma as VP, GM Americas Region

Petach Tikvah, Israel and Zug, Switzerland (ots/PRNewswire) - Sarah Otten will lead Medison's Americas region covering Canada and Latin America. Sarah brings vast geographical expansion experience in international markets. Medison Pharma ("Medison"), a global pharma company focused on providing access to highly innovative therapies to patients in international markets ("Medison"), is proud to announce the joining of Sarah ...

LKQ Europe

LKQ Branding Transformation Continues with new Website and Newsroom Launch for LKQ Europe

Klarpay AG

Klarpay AG adds 70+ Currencies to enable Cross-Border International Payments

Zug, Switzerland (ots/PRNewswire) - Klarpay AG has completed another milestone with the integration of Visa's B2B Connect product to its services. This latest achievement enables Klarpay's business customers to perform cross-currency outbound payments from Klarpay accounts to 90+ countries and 70+ currencies via its Dashboard and APIs. Swiss fintech Klarpay AG has ...

LKQ Europe

LKQ Europe Partners with Think Tank “Project Zebra” to Strengthen Supply Chain Agility

Zug, Switzerland (ots) - The industry leader in the automotive aftermarket is improving its ability to sense and adapt to the increasing volatility in its markets by participating in an innovative supply chain planning pilot project. LKQ Europe is accelerating the move towards an efficient and sustainable supply chain by pushing for more innovation and digitalization. ...

Virtual Pangea

Virtual Pangea and Moretti Fine Art Gallery Announce Partnership to bring Old Masters Art into the Metaverse

Zug, Switzerland (ots/PRNewswire) - Moretti Fine Art Gallery Set to Inaugurate Virtual Pangea's Block-0 Blockchain innovator Virtual Pangea AG (www.virtualpangea.com) announces its partnership with the critically acclaimed Moretti Fine Art Gallery, set to open its first virtual gallery in the company's metaverse ...

LKQ Europe

2

LKQ Europe is Committed to Becoming a Net-Zero Emissions Company

LKQ Europe

1

5

LKQ Expects Major Savings in Cost and CO2 from Traction Battery Repair and Remanufacturing

Micreos

Micreos Pharmaceuticals announces success of its XZ.700 technology in selectively eliminating Staphylococcus aureus pathogen without triggering resistance

Zug, Switzerland (ots/PRNewswire) - In a new publication, the company's flagship compound proves effective in targeting the harmful pathogen while preserving a healthy microbiome Micreos Pharmaceuticals today announces findings from a study proving the effectiveness of XZ.700, a novel antibacterial enzyme, in ...

MoonLake Immunotherapeutics AG

MoonLake Immunotherapeutics to initiate global Phase 2 study of the Nanobody® Sonelokimab in patients with moderate-to-severe hidradenitis suppurativa with HiSCR75 as the primary endpoint

Zug, Switzerland (ots/PRNewswire) - - This Phase 2 study represents an important step in hidradenitis suppurativa ("HS") clinical development, as it will be the first to use the higher clinical response level of HiSCR75 as the primary endpoint - Expected to enroll over 200 patients with moderate-to-severe HS to ...

4ARTechnologies

Art & Technology innovator 4ARTechnologies completes its unique ecosystem with secure NFT marketplace for physical and digital artworks

4ARTechnologies

4ARTechnologies - Market Leader in Art Security and Digitization Develops the World's First Secure NFT for Physical and Digital Artworks

Sequent Ltd.

Revolutionary automatic self-charging smart watch: Sequent - SuperCharger²

Swiss Shakti Stiftung

Satoshi's TAKE-TWO: New blockchain protocol poised to bring digital currency to the masses

Primex Pharmaceuticals

Primex Pharmaceuticals and Nordic Group Sign a Strategic Partnership to Commercialise OZALIN® in France

Paris and Zug, Switzerland (ots/PRNewswire) - Nordic Group, a pharmaceutical company focusing on the development and commercialisation of hospital and orphan products, and Primex Pharmaceuticals AG, an innovative global Anaesthesia pharmaceutical company, announced a strategic agreement today to launch OZALIN® in ...

Primex Pharmaceuticals

Primex Pharmaceuticals and POA Pharma Sign a Strategic Partnership to Commercialise OZALIN in the Nordic Region

Gothenburg, Sweden and Zug, Switzerland (ots/PRNewswire) - POA Pharma Scandinavia AB, a market-oriented Boutique Healthcare Company, working in close contact with healthcare organizations, professionals and hospitals in Nordic countries and Primex Pharmaceuticals AG, an innovative Anaesthesia pharmaceutical company, ...

Hitachi Medical Systems Europe Holding AG

2

Hitachi Medical Systems Europe introduces the third generation of non-invasive intracardiac blood flow visualization technology, at EuroEcho Imaging 2018

Mio Decentral AG

Swiss Start up Mio Decentral creates new crypto currency / Financial Market Authority confirms #MIO as payment token

Hitachi Medical Systems Europe Holding AG

Hitachi Medical Systems Europe wins the contract to supply 6 ultrasound systems in the UK helping to improve prostate cancer diagnosis ...

Zug, Switzerland (ots) - Hitachi Medical Systems Europe wins the contract to supply 6 ultrasound systems in the UK helping to improve prostate cancer diagnosis as part of the innovative RAPID programme at three major hospitals across South West London The new RAPID (Rapid Assessment Prostate Imaging and Diagnosis) ...

TEND

TEND, the Experiential Investment Platform, Announces Token Sale That Will Spearhead New Token Sale Standards

Zug, Switzerland (ots/PRNewswire) - TEND selected by ETH Zurich Chair of Entrepreneurship to serve as research model for token sales TEND, the blockchain-powered experiential investment platform, announced in November 2017 by former Credit Suisse Chief Digital Officer, Marco Abele, today announced its upcoming Token ...

Shire Pharmaceuticals Group Plc

Shire Announces EMA Validation of Veyvondi[TM] [Von Willebrand Factor (Recombinant)] Marketing Authorization Application for Treatment of Von Willebrand Disease

Zug, Switzerland (ots/PRNewswire) - VEYVONDI is the first and only recombinant von Willebrand factor treatment for adults with von Willebrand disease, the most common inherited bleeding disorder[1],[2],[3] Shire plc (LSE: SHP, NASDAQ: SHPG), the leading biotechnology company focused on serving individuals with rare ...

Shire Pharmaceuticals Group Plc

Shire to Highlight New Research Into Chronic Hypoparathyroidism at the European Congress of Endocrinology

Zug, Switzerland (ots/PRNewswire) - New clinical and real-life data in chronic hypoparathyroidism, to advance understanding of this rare disease and improve patients' lives Shire plc (LSE: SHP, NASDAQ: SHPG), the global leader in rare diseases, announced today new research to be presented on rhPTH(1-84) and on the ...

Shire Pharmaceuticals Group Plc

Shire Granted EU Conditional Marketing Authorisation for Natpar[®] (Parathyroid Hormone) for the Treatment of Patients with Chronic Hypoparathyroidism

Zug, Switzerland (ots/PRNewswire) - Natpar is the first and only licensed recombinant human parathyroid hormone therapy for chronic hypoparathyroidism Shire plc (LSE: SHP, NASDAQ: SHPG) today announced that the European Commission (EC) has granted Conditional Marketing Authorisation for Natpar (rhPTH[1-84]), the ...

Shire Pharmaceuticals Group Plc

Shire Launches #PIPostsThanks Social Campaign to Raise Awareness of Primary Immunodeficiency (PI)

Zug, Switzerland (ots/PRNewswire) - Shire launches campaign to raise global awareness during World PI Week Shire plc (LSE: SHP, NASDAQ: SHPG), the global leader in rare diseases, is launching #PIPostsThanks, a social campaign to spotlight the unsung heroes who make a difference in the lives of people living with primary immunodeficiency (PI). PI is a group of nearly ...